Hemostats And Tissue Sealants Market Report 2026

Hemostats And Tissue Sealants Market Overview

• Hemostats And Tissue Sealants market size has reached to $4.35 billion in 2025 • Expected to grow to $5.97 billion in 2030 at a compound annual growth rate (CAGR) of 6.5% • Growth Driver: Increase In Surgical Procedures Fueling The Growth Of The Market Due To Rising Chronic Disease Prevalence And Demand For Effective Bleeding Control • Market Trend: Enhanced Hemopatch With Ready-To-Use Collagen Pad And Room Temperature Storage Launched To Elevate Surgical Outcomes • North America was the largest region in 2025.

What Is Covered Under Hemostats And Tissue Sealants Market?

Hemostats and tissue sealants refers to products used during surgical procedures to control bleeding (hemostasis) and seal tissues to prevent leakage of fluids such as blood or air. Hemostats help stop bleeding by promoting clot formation or mechanically clamping blood vessels, while tissue sealants are applied to close wounds or surgical incisions, aiding in faster healing and reducing the risk of complications. The main types of hemostats and tissue sealants are topical hemostats, adhesives and tissue sealants, fibrin sealants, and others. Topical hemostats refer to substances or materials applied directly to a bleeding site to help stop bleeding during surgical or trauma situations. These are made from compositions such as biological-based, synthetic-based, and combinations and are distributed through various distribution channels such as direct sales, distributors, and online sales and are used in various applications such as surgical procedures, trauma cases, cardiovascular surgery, general surgery, and others and cater to several end users such as hospitals, ambulatory surgical centers (ASCs), specialized clinics, and research and academic institutes.

What Is The Hemostats And Tissue Sealants Market Growth Forecast?

The hemostats and tissue sealants market size is expected to see strong growth in the next few years. It will grow to $5.97 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to development of next-generation tissue adhesives, rising minimally invasive surgeries, growing cardiovascular and trauma surgeries, increased research in hemostasis technologies, expansion of direct and online distribution channels. Major trends in the forecast period include rising adoption of advanced hemostatic products, increased use of synthetic and combination sealants, expansion of cardiovascular and trauma surgeries, focus on minimally invasive and faster recovery procedures, growing research and academic applications in hemostasis.

Global Hemostats And Tissue Sealants Market Segmentation

1) By Product Type: Topical Hemostats, Adhesives And Tissue Sealants, Fibrin Sealants, Other Product Types 2) By Composition: Biological Based, Synthetic Based, Combination 3) By Distribution Channel: Direct Sales, Distributors, Online Sales 4) By Application: Surgical Procedures, Trauma Cases, Cardiovascular Surgery, General Surgery, Other Applications 5) By End-Users: Hospitals, Ambulatory Surgical Centers (ASCs), Specialized Clinics, Research And Academic Institutes Subsegments: 1) By Topical Hemostats: Mechanical Hemostats, Active Hemostats, Flowable Hemostats, Combination Hemostats 2) By Adhesives And Tissue Sealants: Synthetic Tissue Adhesives, Biological Tissue Adhesives, Cyanoacrylate-Based Adhesives 3) By Fibrin Sealants: Liquid Fibrin Sealants, Patch-Based Fibrin Sealants 4) By Other Product Types: Gelatin-Based Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats

What Is The Driver Of The Hemostats And Tissue Sealants Market?

The rising number of surgical procedures is expected to propel the growth of the hemostats and tissue sealants market going forward. Surgical procedures refer to medical operations involving the manual and instrumental techniques performed by surgeons to diagnose, treat, or remove diseased tissues or organs or to repair bodily functions. The rising number of surgical procedures is due to the increasing prevalence of chronic diseases that often require surgical intervention for effective management, treatment, or complication prevention. Hemostats and tissue sealants help surgical procedures by effectively controlling bleeding and sealing tissues, thereby reducing complications and improving surgical outcomes. For instance, in June 2024, according to the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional body for board-certified aesthetic plastic surgeons, there was a 5.5% rise in surgical procedures in 2023, with more than 15.8 million surgeries and 19.1 million non-surgical procedures performed globally. Therefore, the rising number of surgical procedures is driving the growth of the hemostats and tissue sealants industry.

Key Players In The Global Hemostats And Tissue Sealants Market

Major companies operating in the hemostats and tissue sealants market are Johnson & Johnson, Medtronic plc, Becton Dickinson and Company (BD), Stryker Corporation, Baxter International Inc., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, Integra LifeSciences Holdings Corporation, Corza Medical Inc., Artivion Inc., Ethicon Inc., Advanced Medical Solutions Group plc, Marine Polymer Technologies Inc., Samyang Holdings Corporation, 3-D Matrix Medical Technology Co Ltd., GELITA AG, BioCer Entwicklungs-GmbH, AEGIS Lifesciences Pvt. Ltd., Betatech Medical Ltd., Cohera Medical Inc.

Global Hemostats And Tissue Sealants Market Trends and Insights

Major companies operating in the hemostat and tissue sealants market are focusing on developing advanced products, such as ready-to-use absorbable collagen pads hemostat, to improve efficiency and outcomes in surgical care. Ready-to-use absorbable collagen pads of hemostat feature bioactive, resorbable materials that offer immediate application without preparation, enabling quick and effective tissue and dura sealing as well as hemostasis. For instance, in April 2025, Baxter International Inc., a US-based healthcare company, launched Hemopatch Sealing Hemostat with room temperature storage at a symposium in Austria. The new room temperature Hemopatch sealing hemostat offers ready-to-use convenience without the need for pre-warming, enabling rapid application during surgery. It is an innovative absorbable pad that can be applied directly during both open and minimally invasive surgeries, eliminating the need for product preparation or refrigeration. The product's strong adhesive properties, extended shelf life, and rapid hemostatic effect help surgeons manage bleeding or leakage more efficiently, ultimately supporting improved surgical precision and patient recovery across various specialties.

What Are Latest Mergers And Acquisitions In The Hemostats And Tissue Sealants Market?

In March 2024, Advanced Medical Solutions Group PLC, a UK-based medical technology company, acquired Peters Surgical SAS for $154.6 million. Through this acquisition, Advanced Medical Solutions aims to expand its surgical portfolio, strengthen its presence in key European markets, and enhance its position in the global wound care and closure technologies market. Peters Surgical SA is a France-based manufacturer of medical devices and instruments that specializes in hemostats and tissue sealants.

Regional Outlook

North America was the largest region in the hemostats and tissue sealants market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Hemostats And Tissue Sealants Market?

The hemostats and tissue sealants market consists of sales of gelatin-based hemostats, fibrin sealants, oxidized regenerated cellulose, thrombin-based hemostats, and cyanoacrylate-based tissue adhesives. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.